Filter Results
:
(689)
Show Results For
-
All HBS Web
(1,232)
- People (5)
- News (329)
- Research (689)
- Events (1)
- Multimedia (16)
- Faculty Publications (441)
Show Results For
-
All HBS Web
(1,232)
- People (5)
- News (329)
- Research (689)
- Events (1)
- Multimedia (16)
- Faculty Publications (441)
Sort by
- 28 Jun 2010
- HBS Case
Cincinnati Children’s Hospital Medical Center
Health-care reform is more than a political football. For twenty years it's been a ground-level topic of increasing importance for the administrators, physicians, nurses, and frontline employees who interact with patients every day....
View Details
- 29 Jan 2019
- First Look
New Research and Ideas, January 29, 2019
consider a number of interrelated pricing challenges. Founded in late 2013, PatientPing sold a software platform that allowed health care providers to receive real-time notifications (“Pings”) when one of their View Details
Keywords:
Dina Gerdeman
- January 2013
- Supplement
The Great East Japan Earthquake (C): Ishinomaki Kouwan Hospital's Response
By: Hirotaka Takeuchi, Yukiko Sakai, Rebecca Agonafir, Peter Cholewinski, Allison Kean and Emily Kloeblen
On the evening of March 11, 2011, Mayama Fumihiro, the Managing Director of Ishinomaki Kouwan Hospital knew that it would be a long, cold night. The 103 staff members and 162 patients and families were huddled on the top two floors of the four-story hospital, where...
View Details
Keywords:
East Japan;
Earthquake;
Ishinomaki Kouwan Hospital;
Natural Disasters;
Crisis Management;
Health Care and Treatment;
Health Industry;
Japan
Takeuchi, Hirotaka, Yukiko Sakai, Rebecca Agonafir, Peter Cholewinski, Allison Kean, and Emily Kloeblen. "The Great East Japan Earthquake (C): Ishinomaki Kouwan Hospital's Response." Harvard Business School Supplement 713-440, January 2013.
- 08 Aug 2017
- First Look
First Look at Research and Ideas, August 8, 2017
hospitals and established reliability using interrater comparison. Using a factor analysis, we identified three themes of management competencies: management of unit culture, patient flow, and nursing. We constructed patient-level...
View Details
Keywords:
Sean Silverthorne
- 18 Apr 2013
- Working Paper Summaries
The Impact of Pooling on Throughput Time in Discretionary Work Settings: An Empirical Investigation of Emergency Department Length of Stay
- 25 Aug 2010
- Working Paper Summaries
Managerial Practices That Promote Voice and Taking Charge among Frontline Workers
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now...
View Details
Keywords:
by Julie Jette
- December 2017
- Article
Overall Cost Comparison of Gastrointestinal Endoscopic Procedures with Endoscopist- or Anesthesia-Supported Sedation by Activity-Based Costing Techniques
By: Richard A. Helmers, James A. Dilling, Christopher R. Chaffee, Mark V. Larson, Bradly J. Narr, Derek A. Haas and Robert S. Kaplan
Endoscopic/Colonoscopic procedures are done either with gastroenterologist-administered conscious sedation or with anesthesia-administered sedation with propofol. Anesthesia-administered sedation has medical and patient benefits but is more expensive to administer. We...
View Details
Helmers, Richard A., James A. Dilling, Christopher R. Chaffee, Mark V. Larson, Bradly J. Narr, Derek A. Haas, and Robert S. Kaplan. "Overall Cost Comparison of Gastrointestinal Endoscopic Procedures with Endoscopist- or Anesthesia-Supported Sedation by Activity-Based Costing Techniques." Mayo Clinic Proceedings: Innovations, Quality & Outcomes 1, no. 3 (December 2017): 234–241.
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful...
View Details
Keywords:
Product Development;
Leadership;
Health Testing and Trials;
Research and Development;
Risk and Uncertainty;
Financial Condition;
Partners and Partnerships;
Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- 24 Jul 2018
- First Look
New Research and Ideas, July 24, 2018
to change your life. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=54720 in press Health Care Management Review Innovation Contest: Effect of Perceived Support for Learning on Participation By: Jung, Olivia S., Andrea...
View Details
Keywords:
Dina Gerdeman
- August 2017
- Article
Relationship Between Labor and Delivery Unit Management Practices and Maternal Outcomes
By: Avery C. Plough, Grace Galwin, Zhonghe Li, Stuart R. Lipsitz, Shehnaz Alidina, Natalie J. Henrich, Lisa R. Hirschhorn, William R. Berry, Atul A. Gawande, Doris Peter, Rory McDonald, Donna L. Caldwell, Janet H. Muri, Debra Bingham, Aaron B. Caughey, Eugene R. Declercq and Neel T. Shah
OBJECTIVE: To define, measure, and characterize key competencies of managing labor and delivery units in the United States and assess the associations between unit management and maternal outcomes.
METHODS: We developed and administered a management measurement...
View Details
Keywords:
Health Care and Treatment;
Management Practices and Processes;
Performance Evaluation;
Outcome or Result;
United States
Plough, Avery C., Grace Galwin, Zhonghe Li, Stuart R. Lipsitz, Shehnaz Alidina, Natalie J. Henrich, Lisa R. Hirschhorn, William R. Berry, Atul A. Gawande, Doris Peter, Rory McDonald, Donna L. Caldwell, Janet H. Muri, Debra Bingham, Aaron B. Caughey, Eugene R. Declercq, and Neel T. Shah. "Relationship Between Labor and Delivery Unit Management Practices and Maternal Outcomes." Obstetrics & Gynecology 130, no. 2 (August 2017): 358–365.
- April 2024
- Case
Dr. Tom Mihaljevic and Cleveland Clinic
By: Linda A. Hill and Lydia Begag
In December 2022, Dr. Tomislav (“Tom”) Mihaljevic, CEO and President of Cleveland Clinic, was reflecting on the last few years at the hospital, marked both by unprecedented challenges and remarkable achievements. Cleveland Clinic had recently been ranked the world’s...
View Details
Keywords:
Recruitment;
Retention;
Analytics and Data Science;
Digital Transformation;
Digital Platforms;
Innovation and Management;
Innovation Leadership;
Human Capital;
Leadership Development;
Leadership Style;
Leading Change;
Organizational Culture;
Organizational Structure;
Organizational Change and Adaptation;
Mission and Purpose;
Outcome or Result;
Performance Evaluation;
Health Pandemics;
Goals and Objectives;
Health Industry;
Cleveland;
London;
Abu Dhabi;
Florida;
Ohio
Hill, Linda A., and Lydia Begag. "Dr. Tom Mihaljevic and Cleveland Clinic." Harvard Business School Case 424-031, April 2024.
- 30 Aug 2010
- Research & Ideas
Turning Employees Into Problem Solvers
require any number of 100 or 200 services and subprocesses. On top of that, the most knowledgeable people about those subprocesses-the doctors-come and go from the factory and are not employed by it." That complexity makes errors inevitable. And despite the growing...
View Details
- August 2008 (Revised September 2008)
- Case
The Flaxil Label (B)
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite...
View Details
Keywords:
Governance;
Risk and Uncertainty;
Value Creation;
Negotiation;
Attitudes;
Health Care and Treatment;
Government Administration;
Pharmaceutical Industry;
United States
Barron, Greg M. "The Flaxil Label (B)." Harvard Business School Case 909-002, August 2008. (Revised September 2008.)
- February 2021
- Article
Assessment of Electronic Health Record Use Between U.S. and Non-U.S. Health Systems
By: A Jay Holmgren, Lance Downing, David W. Bates, Tait D. Shanafelt, Arnold Milstein, Christopher Sharp, David Cutler, Robert S. Huckman and Kevin A. Schulman
Importance: Understanding how the electronic health record (EHR) system changes clinician work, productivity, and well-being is critical. Little is known regarding global variation in patterns of use.
Objective: To provide insights into which EHR... View Details
Objective: To provide insights into which EHR... View Details
Keywords:
Electronic Health Records;
Health Care and Treatment;
Online Technology;
Health Industry;
Information Technology Industry
Holmgren, A Jay, Lance Downing, David W. Bates, Tait D. Shanafelt, Arnold Milstein, Christopher Sharp, David Cutler, Robert S. Huckman, and Kevin A. Schulman. "Assessment of Electronic Health Record Use Between U.S. and Non-U.S. Health Systems." JAMA Internal Medicine 181, no. 2 (February 2021): 251–259.
- September 2017 (Revised July 2023)
- Case
Adaptive Platform Trials: The Clinical Trial of the Future?
By: Ariel D. Stern and Sarah Mehta
In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer....
View Details
Keywords:
Clinical Trials;
Cancer;
Adaptive Platform Trials;
Platform Trials;
Adaptive Trials;
Glioblastoma;
Health;
Health Care and Treatment;
Health Testing and Trials;
Business Strategy;
Innovation Strategy;
Health Industry;
United States
Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Case 618-025, September 2017. (Revised July 2023.)
- October 2012 (Revised October 2016)
- Case
Predilytics
By: Robert F. Higgins and Annelena Lobb
The management team at Predilytics, a healthcare analytics firm, must decide whether to accept a Series A venture capital financing deal. The company provided analytic services to healthcare plans, typically Medicare Advantage plans, in efforts to draw conclusions from...
View Details
Keywords:
Analytics;
Healthcare;
Medicare;
Health Care and Treatment;
Mathematical Methods;
Health Industry;
New England;
United States
Higgins, Robert F., and Annelena Lobb. "Predilytics." Harvard Business School Case 813-023, October 2012. (Revised October 2016.)
- 28 Feb 2017
- First Look
First Look at New Research, February 28
case:https://cb.hbsp.harvard.edu/cbmp/product/116058-PDF-ENG Harvard Business School Case 817-048 Augmedix In April 2015, Ian Shakil and Pelu Tran, cofounders of Augmedix, are discussing how to grow their emerging health care startup. The...
View Details
Keywords:
Sean Silverthorne
- August 2000
- Case
Developing Nurse Practitioners at the College of St. Catherine
By: Clayton M. Christensen and Sarah S. Khetani
Margaret McLaughlin has just begun her new appointment as the Dean of Health Professions at the College of St. Catherine in Minneapolis/St. Paul, Minnesota. As an education leader, her charge is to develop Minnesota's health care workforce for the future. She is...
View Details
Keywords:
Trends;
Debates;
Decision Choices and Conditions;
Higher Education;
Teaching;
Growth and Development;
Technological Innovation;
Leading Change;
Goals and Objectives;
Value Creation;
Health Industry
Christensen, Clayton M., and Sarah S. Khetani. "Developing Nurse Practitioners at the College of St. Catherine." Harvard Business School Case 601-039, August 2000.
- Article
Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries
By: Ariel Dora Stern, William J. Gordon, Adam B. Landman and Daniel B. Kramer
Objectives:
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
Keywords:
Digital;
Medicine;
FDA;
Health Care and Treatment;
Applications and Software;
Safety;
Cybersecurity;
Medical Devices and Supplies Industry
Stern, Ariel Dora, William J. Gordon, Adam B. Landman, and Daniel B. Kramer. "Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries." BMJ Open 9, no. 6 (June 2019).